A pilot study of the beneficial effects of amantadine in the treatment of painful diabetic peripheral neuropathy.

Abstract

BACKGROUND Current symptomatic treatments for painful peripheral neuropathy in diabetes have variable efficacy in individual patients. Amongst other chemical transmitters involved in pain reception, the N-methyl-D-aspartate (NMDA) subtype of excitatory amino acid receptor is involved in nociception. Amantadine was recently shown to act as a non-competitive… (More)

Topics

Cite this paper

@article{Amin2003APS, title={A pilot study of the beneficial effects of amantadine in the treatment of painful diabetic peripheral neuropathy.}, author={Pina Amin and Nigel D C Sturrock}, journal={Diabetic medicine : a journal of the British Diabetic Association}, year={2003}, volume={20 2}, pages={114-8} }